INTRODUCTION {#SEC1}
============

VDJdb is a comprehensive database of antigen-specific T-cell receptor (TCR) sequences acquired by manual processing of published studies that report the ligand specificities of defined T-cell clonotypes ([@B1]). The primary goal of VDJdb is to facilitate access to existing information on TCR antigen specificities, i.e. the ability to recognize known epitopes presented by known major histocompatibility complex (MHC) class I and II molecules. Our mission is to aggregate TCR specificity information on a continuous basis and establish a curated repository to store these data in the public domain.

During the initial acquisition phase, we paid close attention to the associated metadata, which provide an indication of assay reliability and contribute to an in-depth understanding of TCR interactions with peptide--MHC (pMHC) complexes. An overview of the VDJdb database is provided in Figure [1](#F1){ref-type="fig"}, starting from data acquisition and proofreading routines to downstream analysis tools such as VDJdb browser and a standalone command-line utility that can be used to annotate large datasets containing TCRs with unknown specificities.

![VDJdb overview. The VDJdb database aggregates published and communicated TCR sequences with known antigen specificities. Each VDJdb submission contains descriptions of the TCR α and/or β rearrangement (including the amino acid sequence of the somatically rearranged CDR3 loop), the cognate epitope (peptide sequence, representative parent gene and species) and the restricting MHC allotype, together with methodological details and other metadata. Submissions are checked for syntax errors and data consistency, V and J segments are mapped to the CDR3 sequences to define germline boundaries (V/J segments are inferred if not available in the submission), and a record confidence score is computed based on the methodological metadata. The database can be explored using the VDJdb browser web application, and RepSeq samples can be annotated using a standalone command-line tool. Meta-analysis of the VDJdb database can also facilitate the discovery of antigen-specific TCR motifs.](gkx760fig1){#F1}

VDJdb complements existing popular immunogenetic resources by linking TCR sequences with their pMHC ligands. The IMGT database (<http://www.imgt.org/>, ([@B2])) only stores germline TCR sequence information, while iEDB (<http://www.iedb.org/>, ([@B3])) focuses on antigenic peptide epitopes without any linkage to cognate TCR sequences. VDJdb also complements another recently published TCR sequence annotation resource, the McPAS-TCR database ([@B4]). McPAS-TCR lists associations between TCR sequences and various pathologies, while VDJdb provides a more epitope-centric approach to TCR annotation, featuring a comprehensive description of TCR:pMHC interactions that largely disregards the underlying biological context.

Our rationale for developing VDJdb was closely allied to the advent of high-throughput sequencing of immune repertoires (RepSeq), a technique that allows the rapid acquisition of millions of distinct TCR sequences from individual samples ([@B5]). A lack of means to interrogate the antigen specificities of sequence-defined TCRs currently limits the information that can be extracted from these vast datasets. The need for VDJdb is highlighted by an emerging recognition that genetic associations with disease outcome can be refined by overlaying somatic rearrangements within the antigen-driven repertoire. For example, specific clonotypes have been shown to modulate the protective effects of human leukocyte antigen (HLA)-B\*27 in HIV-1 infection ([@B6]) and Macaca mulatta (Mamu)-A\*01 in SIV infection ([@B7]). The ability to uncover similar links across a range of immune-mediated conditions will be facilitated by a systematic approach that pairs TCR specificities with high-throughput screening technologies such as RepSeq ([@B8]).

RESULTS {#SEC2}
=======

Data sources and processing {#SEC2-1}
---------------------------

### TCR specificity assays {#SEC2-1-1}

Published studies describing TCR specificity are the primary source of content for VDJdb. Most of the current records describe antigen-specific TCR sequences extracted from pMHC multimer-labeled T-cell populations ([@B9]). These assays are generally reliable if accompanied by high resolution sorting and good flow cytometry practice ([@B10]). Other records describe antigen-specific TCR sequences identified using functional readouts, including *in vitro* assays based on T-cell recognition of targets expressing defined pMHC molecules ([@B11]). Additional verification steps, including post-sort analysis and the expansion and retesting of T-cell clones, are listed in the associated metadata. A summary of available VDJdb records is provided in Table [1](#tbl1){ref-type="table"}.

###### VDJdb summary

  Species            MHC     Gene   Records   Paired   Epitopes   Publications
  ------------------ ------- ------ --------- -------- ---------- --------------
  *Homo Sapiens*     MHCI    TRA    481       310      65         55
  *H. Sapiens*       MHCI    TRB    3001               99         75
  *H. Sapiens*       MHCII   TRA    138       17       12         10
  *H. Sapiens*       MHCII   TRB    451                14         11
  *Macaca Mulatta*   MHCI    TRA    74        0        1          1
  *M. Mulatta*       MHCI    TRB    1313               3          2
  *Mus Musculus*     MHCI    TRA    8         7        8          8
  *M. Musculus*      MHCI    TRB    8                  8          8
  *M. Musculus*      MHCII   TRA    8         8        8          6
  *M. Musculus*      MHCII   TRB    9                  8          6
  Overall                           5491      413      132        105

The number of TCR sequence records, epitopes and publications for each species, MHC class and TCR chain in the database. The 'Paired' column displays the number of records with known TCR α--β pairs. Statistics are calculated based on compiled VDJdb data from the 2 February 2017 database release.

### Grooming reported TCR sequences {#SEC2-1-2}

Common problems with published TCR specificity data include a lack of V and J segment specification, and incomplete (i.e. lacking conserved CDR3 residues) or excessive (e.g. including the conserved F residue in the J segment FGXG motif) CDR3 sequences. Such database records greatly complicate direct comparisons with immune repertoire sequencing data and the computation of summary statistics. We have therefore implemented an additional data processing step that involves: (i) removing excessive or adding missing germline CDR3 residues; (ii) resolving V and J segments by mapping to the germline database; and (iii) highlighting records that could not be repaired or do not match the V/J segment assignments reported by the authors.

Sequence assignment reliability {#SEC2-2}
-------------------------------

False-positive identification of antigen-specific TCR sequences can arise from several methodological issues, including non-specific pMHC multimer staining and low resolution cell sorting ([@B9],[@B10]). We have therefore implemented a confidence scoring system that accounts for: (i) the frequency of the TCR clone or clonotype in the acquired sample of antigen-specific TCRs; (ii) the reliability of the TCR sequencing method (Sanger sequencing, high-throughput sequencing or single-cell sequencing); and (iii) the use of additional validation procedures (e.g. functional assays). The confidence scoring system implemented for VDJdb categorizes records into four different groups, from low confidence/no information (score = 0) to very high confidence (score = 3), and largely corresponds with the probability of a given TCR:pMHC pair being independently validated in different donors and/or studies (Table [2](#tbl2){ref-type="table"}). The scoring is described in the database specification \[<https://github.com/antigenomics/vdjdb-db/blob/master/README.md>\].

###### VDJdb scoring evaluation

  VDJdb score   Multiple samples   Multiple studies   Count       Percent
  ------------- ------------------ ------------------ ----------- ---------
  0             −                  −                  1709/1918   89%
                \+                 −                  166/1918    9%
                \+                 \+                 43/1918     2%
  1             −                  −                  751/970     77%
                \+                 −                  163/970     17%
                \+                 \+                 56/970      6%
  2             −                  −                  211/348     61%
                \+                 −                  27/348      8%
                \+                 \+                 110/348     32%
  3             −                  −                  87/138      63%
                \+                 −                  9/138       7%
                \+                 \+                 42/138      30%

The number and percentage of TCR:pMHC records that were reported only once, or found in multiple independent samples and/or studies for each VDJdb score value (from 0 to 3, higher score indicates higher confidence). Only human TCR β sequence records were considered.

Database infrastructure and analysis tools {#SEC2-3}
------------------------------------------

### Database specification, hosting and data submission {#SEC2-3-1}

A detailed specification of the VDJdb database is available online \[<https://github.com/antigenomics/vdjdb-db/blob/master/README.md>\], including information related to the TCR sequence, the cognate epitope and the restricting MHC allotype, together with methodological outlines and associated metadata (Figure [1](#F1){ref-type="fig"}). An XLS template for database submission is also available in the VDJdb repository. VDJdb storage, submission and proofreading infrastructure is centered around the GitHub web-based repository hosting service (<https://github.com>). Processed and pending publications are listed in the issues section, database submissions are handled as pull requests, and proofreading uses TravisCI continuous integration (<https://travis-ci.org>). Scripts required to assemble the database from the list of submissions, proofread, fix CDR3 sequences and assign confidence scores are included in the VDJdb repository.VDJdb web interface. A web-based GUI application for VDJdb browsing is available at <https://vdjdb.cdr3.net/>. The VDJdb browser allows the database to be queried for specific antigens or TCR sequences, and filtered based on parent species, V/J segments, MHC allotypes, antigen host species and/or TCR specificity assay-related metadata. Results can be exported as CSV and/or XLS tables.

### VDJdb annotation tool {#SEC2-3-2}

A standalone VDJdb annotation tool \[<https://github.com/antigenomics/vdjdb-standalone>\] was developed using the VDJtools framework ([@B12]). The tool can be used to annotate RepSeq samples processed through a variety of different software applications. It also generates comprehensive lists of clonotype matches, as well as annotation summary tables, and supports both exact CDR3 matching and hamming distance-based searches.

VDJdb application examples {#SEC2-4}
--------------------------

### Network structure of VDJdb records {#SEC2-4-1}

Aggregated VDJdb records can be visualized as a network by constructing a graph with nodes corresponding to CDR3 amino acid sequences and edges connecting CDR3 amino acid sequences that differ by up to a fixed number of substitutions. The graph of currently available human TCR β CDR3 sequences contains 2300 nodes and 9651 edges, and suggests higher connectivity for records associated with the same antigen (Figure [2A](#F2){ref-type="fig"}, network layout and graphing performed using Cytoscape ([@B13])). Of note, the hamming distance between CDR3 sequences that correspond to the same antigen is lower than the hamming distance between random CDR3 sequence pairs (Figure [2B](#F2){ref-type="fig"}), and TCRs specific for distinct antigens cluster neatly using the number of CDR3 pairs with hamming distances of \<3 substitutions (Figure [2C](#F2){ref-type="fig"}).

![Similarity of TCR sequences specific for defined antigens. (**A**) The network of VDJdb records constructed using hamming distances computed for pairs of CDR3 amino acid sequences. Edges (alignments) connect sequences that differ by up to three amino acid substitutions. Nodes are colored by epitope: red, FRDYVDRFYKTLRAEQASQE (HIV-1/Gag); blue, GLCTLVAML (EBV/BMLF1); green, KRWIILGLNK (HIV-1/Gag); purple, NLVPMVATV (CMV/pp65); black, other epitopes. Node size is scaled by degree. Only human TCR β records were considered. Number of nodes, 2300; number of edges, 9651. (**B**) Frequency of alignments with a given number of substitutions for TCRs specific for the same (blue) or different epitopes (red). Number of same epitope alignments, 5285; number of different epitope alignments, 4366. (**c**) Heatmap showing the normalized number of alignments between each pair of epitope specificities. The diagonal indicates alignments within the same epitope specificity. Normalization was performed by dividing each entry of the alignment count matrix by the product of the corresponding row and column sums.](gkx760fig2){#F2}

### TCR motif inference {#SEC2-4-2}

The clonotypic architecture of antigen-specific T-cell populations is highly variable, ranging from epitopes that recruit a broad repertoire of diverse TCRs to epitopes that recruit a narrow repertoire of highly conserved TCRs, which can be exploited by viral escape mutations ([@B14]). Several epitopes in the VDJdb database are associated with a high number of unique TCR β CDR3 sequences, potentially enabling the identification of epitope-specific amino acid residues on the basis of CDR3 sequence similarity. Basic motif inference can be performed by selecting the most frequent connected subgraph for a given antigen and constructing length-identical position weight matrices (PWMs) ([@B15]). As an example, Figure [3A](#F3){ref-type="fig"} and [B](#F3){ref-type="fig"} show CDR3 sequence graphs for the GILGFVFTL epitope from the influenza A virus matrix protein and the GLCTLVAML epitope from the Epstein--Barr virus BMLF1 protein. The selected sequences display a high degree of similarity and combine to generate a PWM with defined hot-spot positions for each epitope specificity (Figure [3C](#F3){ref-type="fig"} and [D](#F3){ref-type="fig"}). Of note, the CDR3 positions with the highest information content (neglecting germline bias from the V and J segments) in the PWMs juxtapose with TCR β CDR3:pMHC contacts defined by X-ray crystallography (Protein Data Bank accession codes: GILGFVFTL, 2vlk and 2vlr; GLCTLVAML, 3o4l).

![CDR3 motifs discovered from comparative analyses of VDJdb records. (**A** and **B**) Networks of pairwise alignments of GILGFVFTL-specific (A) and GLCTLVAML-specific (B) TCR β CDR3 sequences with up to three amino acid substitutions (no indels allowed). Nodes from the largest connected subnetworks (29 for GILGFVFTL and 36 for GLCTLVAML) used for motif discovery are shown in red. (**C** and **D**) TCR β CDR3 amino acid sequence logos and contact energy matrices obtained from available TCR:pMHC structural data. Sequence logos generated using WebLogo (<http://weblogo.berkeley.edu/logo.cgi>) show the relative frequency of each amino acid at each given position, and the height of each amino acid stack is scaled by the information content at each given position. Contact matrices are colored according to the interaction energies for each pair of CDR3 and peptide antigen residues (single-point energies were computed using GROMACS, value negated), and facet headers denote the Protein Data Bank IDs. Stars above the sequence logos show the number of accessible peptide antigen residues for each CDR3 residue, computed by counting peptide antigen residues closer than 5 Å to each given CDR3 residue.](gkx760fig3){#F3}

### Annotation of immune repertoire sequencing data {#SEC2-4-3}

To demonstrate the utility of VDJdb as a tool for the annotation of large-scale RepSeq data, we selected two recently published datasets: (i) TCR sequences from CD4 and CD8 T-cell subsets isolated from donors stratified for age and CMV status ([@B16]); and (ii) pooled TCR sequences from an aging study ([@B17]).

In the first study, matching of CMV-specific and EBV-specific TCR β (TRB) sequences revealed a clear enrichment of specific variants in the memory CD8 T-cell subset, while the fraction of TRB reads that matched VDJdb records in the CD4 and naive CD8 T-cell subsets fell below an *ad hoc* threshold of 0.1% (Figure [4](#F4){ref-type="fig"}, left panel). A detailed subanalysis further showed that CMV-specific CD8 T-cells were present in different memory compartments in a CMV-seropositive donor but not in a CMV-seronegative donor (Figure [4](#F4){ref-type="fig"}, right panel).

![Annotation of TCR β (TRB) repertoires obtained from a study of naive (N) and memory (M) CD4 and CD8 T-cells ([@B16]). Five independent peripheral blood samples were analyzed per donor. The plot shows the fraction of TRB reads with matches to known CMV-specific or EBV-specific TCR β sequences in VDJdb. A detailed analysis of the memory CD8 T-cell subset in donor 7 (CMV-seronegative) and donor 8 (CMV-seropositive) is shown on the right. CM, central memory; EM, effector memory; TEM, terminally differentiated effector memory. The dashed line shows an ad hoc threshold of 0.1%, corresponding to the upper limit of specific TRB reads among naive T-cells.](gkx760fig4){#F4}

In the second study, an analysis of specific TCR abundance in peripheral blood showed clear age-related trends for common and rare antigens. Across the cohort, a general decrease in the number of naive T-cells ([@B17]) was compensated by clonal expansions specific for common persistent viruses such as CMV and EBV ([@B18]), while the overall T-cell pool was depleted of clonotypes specific for rarer persistent viruses such as HCV and HIV (Figure [5](#F5){ref-type="fig"}). This result supports the notion that aging is associated with a progressive loss of clonal diversity that negatively impacts the ability to mount *de novo* immune responses ([@B19]).

![Abundance of TCR β (TRB) sequences specific for common (CMV and EBV) or less common persistent viruses (HCV and HIV) in peripheral blood samples from healthy donors of various ages (*n* = 65) ([@B17]). The plot shows the fraction of specific TRB reads divided by the mean value observed in umbilical cord blood (UCB) samples (*n* = 8). Z-scores were computed by comparing the TRB read fraction value in each donor with the corresponding mean and standard deviation values in UCB samples.](gkx760fig5){#F5}

DISCUSSION {#SEC3}
==========

Starting from the February 2017 release, VDJdb features more than 5000 records of mouse, monkey and human TCR sequences aggregated from more than 100 published studies, collectively spanning more than 100 different epitopes presented by MHC class I or class II. Various metadata are stored in addition to assess the quality of reported specificity assays and provide a confidence score for each database record. A proofreading step that automates TCR sequence annotation across the VDJ junction has also been included to ensure the consistency of records derived from studies using different nomenclatures and reporting styles.

As demonstrated above, VDJdb is a versatile resource that can be used to annotate large-scale TCR repertoire sequencing datasets and infer antigen-specific TCR motifs. Accordingly, VDJdb can be used as a benchmark for novel machine learning strategies designed to identify targeted antigens from primary TCR sequence data ([@B20],[@B21]). Such approaches (e.g. performing fuzzy matching of TCR sequence motifs instead of relying on exact sequence matches) can extend coverage of the database and potentially enable comprehensive annotation of the entire set of possible TCR sequences, which can reach far beyond the estimate of 10^∧^10 variants for human TCR β chains \[<https://arxiv.org/abs/1604.00487>\]. In addition, VDJdb can serve as one of the building blocks in a platform that integrates TCR specificity and peptide binding affinity data to solve one of the most ambitious and challenging tasks in the field, i.e. predicting T-cell recognition of a pMHC complex from the amino acid sequence of the TCR. The latter promises to increase the overall utility of immune repertoire sequencing technology in basic immunological research ([@B22]). Numerous applications can also be envisaged in translational settings. For example, accurate *in silico* predictions of TCR specificity would greatly facilitate cancer immunotherapy studies that rely on the adoptive transfer of tumor-specific T-cells ([@B23]).

The future development of VDJdb must interface with the emerging trend of switching from conventional (Sanger) sequencing to high-throughput techniques for the analysis of antigen-specific TCRs. Although sequencing the entire repertoire of an antigen-selected T-cell population will greatly increase method yield and allow the capture of low-frequency variants, it will eventually lead to the problem of distinguishing truly enriched TCR sequences from cellular contaminants and molecular artefacts. Model experiments incorporating rigorous controls, such as parallel comparisons of different sequencing methodologies with biological and procedural replicates, will therefore be required to assess reliability and develop guidelines for the management of datasets generated across diverse experimental and technical platforms.

DATA AVAILABILITY {#SEC4}
=================

VDJdb dataset is freely available under the Creative Commons Attribution-NoDerivatives 4.0 International license at <https://github.com/antigenomics/vdjdb-db>. VDJdb compilation and proofreading scripts are freely available under the Apache 2.0 license.
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